Abstract:
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous
condition, predominantly occurs as a result of drug reaction.
We hereby, present the first case of AGEP following treatment with
remdesivir in a patient with COVID-19 without hydroxychloroquine use
which serves as a reminder for considering remdesivir as a possible
causative agent when dealing with AGEP presentation in COVID patients.